- Topics
- Christopher Morten
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law
In the Media
- News From Columbia Law
- In the Media
The media looks to Columbia Law experts to provide ideas, opinions, analysis, and commentary on news of the day. Explore more below.
Searching by
September 13, 2023
STAT
In New Regeneron Deal for COVID Drug, White House Imposes Price Limits for First Time
- Areas of Study
- Administrative Law and Public Policy
- Topics
- Christopher Morten
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law
- Areas of Study
- Intellectual Property and Technology
- Topics
- Christopher Morten
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law
July 22, 2023
The New York Times
How a Drugmaker Profited by Slow-Walking a Promising H.I.V. Therapy
- Areas of Study
- Intellectual Property and Technology
- Topics
- Christopher Morten
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law
- Areas of Study
- Intellectual Property and Technology
- Topics
- Christopher Morten
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law
May 31, 2023
Fierce Pharma
U.S. Appeal in High-Stakes Gilead Patent Case Garners Support From Patient Advocates
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law
May 02, 2023
STAT
A Battle Between Gilead and the U.S. Government Over Patents on HIV Prevention Pills Goes to Trial
- Topics
- Christopher Morten
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law
- Topics
- Christopher Morten
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law
April 18, 2023
See generally | University of Pennsylvania Law Review
A Conversation With Professor Chris Morten
- Topics
- Christopher Morten
- Featured Faculty
- Christopher Morten Associate Clinical Professor of Law